Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: A cross-over study

Medical-eligibility criteria for contraceptive use

John Guillebaud · The Lancet · 2001 · 1.1K citations

Social Sciences, Demography, Population Health Sciences +14

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

Hershel Jick, Susan S. Jick, Michael W. Myers et al. · The Lancet · 1995 · 735 citations

Medicine, Endocrinology, Obstetrics +17

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study

The Lancet · 1995 · 507 citations · Full text

Medicine, Gynecology, Obstetrics +16

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Poulter Nr, Chang Cl, Farley Tm et al. · PubMed · 1995 · 404 citations

Medicine, Gynecology, Obstetrics +17

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives

Jan Rosing, Guido Tans, Gerry A. F. Nicolaes et al. · British Journal of Haematology · 1997 · 331 citations · Full text

Medicine, Gynecology, Obstetrics +12